Works matching IS 03407004 AND DT 2012 AND VI 61 AND IP 12
Results: 17
A naturally processed HLA-DR-bound peptide from the IL-9 receptor alpha of HTLV-1-transformed T cells serves as a T helper epitope.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2215, doi. 10.1007/s00262-012-1284-7
- By:
- Publication type:
- Article
Phase II trial of hu14.18-IL2 for patients with metastatic melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2261, doi. 10.1007/s00262-012-1286-5
- By:
- Publication type:
- Article
Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin's lymphoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2207, doi. 10.1007/s00262-012-1285-6
- By:
- Publication type:
- Article
Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2227, doi. 10.1007/s00262-012-1257-x
- By:
- Publication type:
- Article
Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2239, doi. 10.1007/s00262-012-1290-9
- By:
- Publication type:
- Article
Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2251, doi. 10.1007/s00262-012-1289-2
- By:
- Publication type:
- Article
Mast cells impair the development of protective anti-tumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2273, doi. 10.1007/s00262-012-1276-7
- By:
- Publication type:
- Article
Analysis of pre-treatment markers predictive of treatment benefit for the therapeutic cancer vaccine MVA-5T4 (TroVax).
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2283, doi. 10.1007/s00262-012-1302-9
- By:
- Publication type:
- Article
The new aspects of immunotherapy in prostate cancer.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Using the allergic immune system to target cancer: activity of IgE antibodies specific for human CD20 and MUC1.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2295, doi. 10.1007/s00262-012-1299-0
- By:
- Publication type:
- Article
EGCG targeting efficacy of NF-κB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2321, doi. 10.1007/s00262-012-1301-x
- By:
- Publication type:
- Article
Induction of T cell responses and recruitment of an inflammatory dendritic cell subset following tumor immunotherapy with Mycobacterium smegmatis.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2333, doi. 10.1007/s00262-012-1291-8
- By:
- Publication type:
- Article
Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8 T cells in vivo.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2343, doi. 10.1007/s00262-012-1307-4
- By:
- Publication type:
- Article
Effective modulation of CD4CD25 regulatory T and NK cells in malignant patients by combination of interferon-α and interleukin-2.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2357, doi. 10.1007/s00262-012-1297-2
- By:
- Publication type:
- Article
Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2311, doi. 10.1007/s00262-012-1298-1
- By:
- Publication type:
- Article
Vitamin D-binding protein-derived macrophage-activating factor, GcMAF, and prostate cancer.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Clinical safety and pharmacological profile of the HLA-DR antibody 1D09C3 in patients with B cell chronic lymphocytic leukemia and lymphoma: results from a phase I study.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2367, doi. 10.1007/s00262-012-1362-x
- By:
- Publication type:
- Article